|
⚲
|
| Keyboard |
| Zakrzewski Joseph S
✚
|
|
|---|---|
| CIK # | 0001331852 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001331852] | |
| 4 | [0001331852] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AN2 Therapeutics Inc | |
| Zakrzewski Joseph S | |
| Cyteir Therapeutics Inc | |
| Sangamo Therapeutics Inc | |
| Amarin Corp PLC UK | |
| Acceleron Pharma Inc | |
| Insulet Corp | |
| Liposcience Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 99,999 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 10,362 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 10,362 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 99,999 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (Right to Buy) · derivative
|
2026-02-20 | Grant | 20,400 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (Right to Buy) · derivative
|
2025-05-22 | Grant | 19,111 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2025-04-10 | Grant | 10,523 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-12-19 | Grant | 9,816 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-11-27 | Buy | 2,000 | $1.40 | 2,800 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-11-19 | Buy | 5,000 | $1.01 | 5,050 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-11-18 | Buy | 20,000 | $1.00 | 20,000 |
|
AN2 Therapeutics Inc ANTX
Stock Option (Right to Buy) · derivative
|
2024-06-19 | Grant | 64,503 | $0.00 | |
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2024-02-06 | Option exercise | 14,150 | $1.69 | 23,914 |
|
Cyteir Therapeutics Inc CYT
Stock Option (Right to Buy) · derivative
|
2024-02-06 | Option exercise | 14,150 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-18 | Sell | 100,000 | $19.11 | 1,911,000 |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2023-06-07 | Grant | 23,742 | $0.00 | |
|
Cyteir Therapeutics Inc CYT
Stock Option (Right to Buy) · derivative
|
2023-02-03 | Grant | 14,150 | $0.00 | |
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2022-12-07 | Buy | 21,202 | $1.30 | 27,563 |
| showing 20 of 196 most recent transactions | |||||